Background-Interventional cardiologists receive one of the highest levels of annual occupational radiation exposure.
U se of radiation for medical examinations and tests is the largest artificial source of radiation exposure. 1 Radiation for medical use has increased 3-fold since 1980s. 2 Interventional cardiology procedures are only 12% of all radiological procedures but contribute about 48% of the total collective dose in the adult cardiology patient. 3 In contrast to other radiation-based imaging and therapeutic modalities, these fluoroscopic-based procedures are unique in that healthcare workers also receive meaningful radiation doses. Radiation exposure is well known for its stochastic effects (eg, risks of inducing malignant diseases 4 ) and deterministic effects (eg, skin damage as well as cataract formation 5, 6 ).
Although these risks are difficult to quantify, there is increasing awareness in the literature of the ALARA (as low as reasonably achievable) principle and the need to protect the operator and the laboratory staff. 7 A recent case series of predominantly left-sided brain tumors in interventional cardiologists further highlights a potential dose-risk relationship. 8 Healthcare workers using fluoroscopy wear lead but the head is not covered typically. Data suggest that interventional cardiologists' cranial radiation dose is 10-to 20-fold higher than the dose recorded beneath their lead aprons or vests. 9 Therefore, a novel nonlead surgical cap with heavy metals was developed to provide radiation protection for the head but at the same time to be lightweight and comfortable to wear for an entire day of cases.
This study had 2 objectives. We sought to determine the efficacy of (1) a specialized lead shield draped over the patient and (2) the nonlead surgical cap worn by the operator (No Brainer, Radpad, Worldwide Technologies and Innovations, Kansas City, KS) in reducing interventional cardiologists' radiation exposure.
Methods
To answer the first objective, the design was a single-center prospective randomized trial of lead shield draped over the patient versus usual care (no lead shield over patient). To answer the second objective, all interventional cardiologists wore the surgical cap and dosimeters were placed inside and outside the cap at left temporal region to measure radiation dose to the head.
Inclusion criteria were 1 of the following: (1) patients referred for percutaneous coronary intervention (PCI), (2) patients presenting with acute coronary syndrome referred for coronary angiography and possible PCI, and (3) patients with stable angina referred for coronary angiography and high likelihood of undergoing same sitting PCI based on opinion of interventional cardiologist. The only exclusion criterion was patient age <18 years.
Patients were randomly assigned, in a 1:1 ratio, to have their procedure with or without the lead shield use. Online randomization was stratified by planned chronic total occlusion PCI and used variable block randomization. The study was approved by the local ethics committee, and all patients provided informed consent before enrollment. The interventional cardiologist who performed the procedure wore the radiation protection cap in all procedures. Although each operator performed this procedure for multiple patients, the patient, rather than the physician, was randomized because there was no risk of contamination between procedures and the operator effect could be accounted for statistically.
There were 10 interventional cardiologists who participated in this study; they were high volume operators performing at least 300 PCI per year. Two of the operators were dedicated chronic total occlusion (CTO) operators who performed complex CTO procedures. There were 3 interventional fellows in the study. Cardiology residents were not allowed as primary operators in the study.
Radiation Protection and Measurements
Procedures were performed on a digital single-plane cineangiography unit (Philips-Allura) with an undertable x-ray tube. A 25 cm magnification and a frame rate of 15 frames/s were used. During all procedures, the routine measures to reduce radiation exposure (including lead aprons, lead collar, lead lenses, movable ceiling suspended lead shield, and a table mounted lead side shield) were used as per usual practice in our institution. Primary operators performing the procedure were not provided additional formal radiation training as a part of the study.
The lead shield for the patient was a custom-made drape (0.5mm lead equivalent, weight 5 pounds per piece) made of 2 pieces that exceeded the width of the patient with 2 semicircular cut outs on the edge to accommodate femoral vascular access ( Figure 1A ). Lead drapes were placed in sterile bags. The bottom lead drape was placed on the patient after the patient was prepped underneath sterile drape and placed below the femoral arteries with semicircular cut outs at the level of the femoral arteries. The top lead drape was placed on top of sterile drapes to facilitate rapid removal in case imaging of iliac and femoral arteries would be needed. This design allows operators to take postfemoral access sheath angiograms.
The cap used was a novel, paper thin, nonlead surgical cap (No Brainer, 9100-Y RADPAD, lead equivalency 0.125 mm, weight 53 g, list price $6.50 USD; Figure 1B ). It contains bismuth and barium to block radiation and is lead free. The cap was disposable but could be used repeatedly by the same operator over multiple procedures. The operators were given new caps whenever their caps were noticed to be damaged. The cap is to be worn as far down forehead as possible to maximize protection.
Operator radiation exposure was measured using 3 direct readout digital dosimeters (radiation dose in µSv was recorded using Unfors
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• These protective measures can be incorporated into clinical practice and increase operators' safety. Educational Direct Dosimeters [EDD-30]). One dosimeter was placed on the left side of the operator's chest outside the lead apron to measure overall radiation exposure because of scatter radiation. The other 2 dosimeters were placed on the left temporal region of the operator's head (1 external and 1 internal to the cap to assess the efficacy of the cap). Characterization of the performance of the EDD-30 dosimeters in an interventional radiology suite was performed before the study and the results were published separately. 10 The EDD-30 dosimeters responded to increase intensity of radiation with a high degree of linearity (R 2 >0.99; P<0.001) and had high degree of accuracy (R 2 >0.99; P<0.001) when compared with a gold-standard ion chamber. The detection limit of each probe was estimated to be 0.6 µGy with an associated uncertainty of 5%.The dosimeters were reset before every procedure and the operator radiation dose was recorded at the end of each procedure by a trained study coordinator. Similarly, the air kerma at the interventional reference point and fluoroscopy time were recorded at the end of each procedure. Dose area product was not available on the current equipment used in the study.
Trial Outcomes
For the first (lead shield) objective, there were 2 coprimary outcomes: (1) the difference in operator radiation dose (µSv) measured at left breast outside of operator's lead and (2) the difference between operator dose indexed for air kerma (dose/air kerma in µSv/mGy) between the 2 groups. Indexing operator dose for air kerma allows an estimate of benefit for operator after adjusting for dose delivered to patient and therefore would be valuable in case of baseline differences in the procedures. Because air kerma at the interventional reference point is an equipment generated number and not a measurement performed in the laboratory, there is no impact because of shielding. For the second (radiation protection cap) objective, the primary outcome was the difference between total radiation doses as measured by the 2 dosimeters (µSv) at left temporal region of the head of the interventional cardiologist (ie, external dosimeter versus internal dosimeter to the cap).
Operators were also asked to rate the comfort of the cap on a scale of 0 to 10 with 10 being most comfortable after each procedure. This was important as caps that are heavy and uncomfortable are unlikely to be adopted in clinical practice.
Statistical Analysis

Sample Size
Based on mean radiation exposure during femoral PCI of 21 µSv±14 SD in a control sample 11 and assuming normality of distribution for the outcome and a 1-sided α of 5%, 226 patients were required to have 80% power to detect a 25% reduction in the mean operator radiation dose. The Bonferroni correction to control type I error in the context of multiple comparisons (2 coprimary outcomes) was applied, so that P values <0.025 were considered significant for coprimary outcomes.
With a total of 226 patients, we calculated that we would have 98% power with a significance level of 5% to detect a 25% reduction in the mean radiation dose/air kerma ratio (based on a 1-sided t test, mean 0.0317 microSv/mGy±SD of 0.0144 in pretrial mock runs group). Furthermore, assuming the same distribution for the mean radiation dose at the left temporal region of the head (ie, 21±14 µSv), 226 patients would provide 98% power to detect a 25% reduction in the mean radiation dose inside the cap when compared with the dose outside the cap. For the 3 outcomes, reliable estimates of the intraclass correlations (ICC) because of operator were unknown. For the purpose of sample size calculation, they were assumed to be low and with no substantial effect on the study power.
The baseline characteristics were reported as mean (SD) or median (first quartile [Q1], third quartile [Q3]) for continuous variables and count (percent) for categorical variables. The results were CABG indicates coronary artery bypass grafting surgery; NSTEMI, non-ST-segment-elevation myocardial infarction; PCI, percutaneous coronary intervention; and STEMI, ST-segment-elevation myocardial infarction.
*Plus or minus values are mean±SD. †Body mass index is the weight in kilograms divided by the square of the height in meters. Radiation Protect Trial analyzed using the intention-to-treat principle. The outcomes with violation of the normality assumption were transformed to achieve normality. Radiation dose at left breast and radiation indexed by air kerma were transformed using the natural logarithm. The difference between internal and external radiation at the left temporal region was transformed using the third root. Between-group differences in radiation dose at left breast and radiation dose by air kerma were analyzed using a mixed effects linear regression model. Operator effects were included in the analyses of the primary outcomes as a clustering effect because each physician performed this intervention for multiple randomized patients. Subgroup analyses were also performed using mixed effects linear regression. Consistency of the treatment effect was evaluated in 5 clinically relevant subgroups: (1) CTO versus non-CTO, (2) PCI including rotablation versus coronary angiography only, (3) femoral versus radial access, (4) tertiles of patient body mass index, and (5) cardiologist attending versus cardiology trainees (residents and fellows) as the primary operator. For the radiation protection cap objective, the difference between the internal and external radiation doses was analyzed using a mixed effects linear regression model, with operator included as a random effect. The analysis was adjusted for treatment group (lead shield group versus control group). The intraoperator correlation coefficients of the 3 outcomes were estimated using the mixed effects model. The least-squares mean estimates derived from linear mixed models were back transformed.
Results
Between November 2013 and May 2014, 230 patients undergoing coronary angiography or percutaneous coronary intervention at the Hamilton General Hospital, Canada (Figure 2) were enrolled. Two patients were excluded because of technical and logistic issues related to the dosimeters. There were 10 operators and each operator treated 1 to 53 patients. Characteristics of the enrolled patients who underwent randomization were similar in both treatment groups (Table 1) ; 74 (32%) were women, mean age of 66±11.49 (SD) years, and mean body mass index of 30±7.12 (SD) kg/m 2 . The lead shield group had 10 (9%) patients with a previous history of coronary artery bypass grafting surgery compared with 22 (19%) patients in the control group.
Characteristics of the procedures performed were similar in both treatment groups ( Table 2) ; PCI with stenting was performed in 163 (71.5%) of cases, whereas diagnostic angiography only in 60 (26.0%) of cases. Radial access was performed in 172 (75.4%) of procedures, and 18 (7.9%) of procedures were planned chronic total occlusion PCI. Fluoroscopy time, air kerma, and contrast volume were similar in both treatment groups ( Table 2 ).
Lead Shield
Lead shield use resulted in a 76% reduction in operator radiation exposure in the lead shield group (mean left chest radiation, 3.07 [95% confidence interval {CI}, 2.00-4.71] µSv versus 12.57 [8. [14] [15] [16] [17] [18] [19] .40] µSv, P<0.001; ICC=0.078; Table 3 ). The mean left chest radiation dose as a function of air kerma was reduced by 72% (0.004 [95% CI, 0.003-0.005] µSv/mGy versus 0.015 [95% CI, 0.012-0.019] µSv/mGy, P<0.001; ICC=0.028). The lead drape was well tolerated by patients. Only 1 patient who weighed 52 kg asked to remove the drape because she felt that it was heavy. 
Nonlead Surgical Cap
The surgical cap use showed a significant reduction in operator head radiation exposure (mean left temporal difference [external-internal] radiation dose was 4.79 [95% CI, 3.30-6.68] µSv, P<0.001; ICC=0.027; Table 4 ). Significant reductions of head dose with cap occurred in both lead drape group (2.73 with 95% CI, 1.76-4.00; P<0.001) and nonlead group (7.69 with 95% CI, 5.64-10.19; P<0.001).
Median operator comfort level with cap during the procedure on a 1-to 10-point scale was 9.
Subgroup Analyses
There were consistent reductions in operator radiation exposure in the lead shield group compared with the control group within all prespecified subgroups ( Table 5 ). There appeared to be a greater reduction in dose among femoral cases (P=0.002 for interaction). There were also consistent reductions in operator head radiation exposure within all prespecified subgroups ( Table 6 ).
Discussion
The Radiation Protect study clearly demonstrates that a specialized lead drape placed over the patient reduces operator radiation dose to the left chest by 76% and simple lightweight cap can significantly reduce cranial dose. These simple interventions can reduce lifetime radiation dose to the primary operator by almost 3 quarters which is important for health professionals over a 30-to 40-year career.
Recent case series of predominantly left-sided brain malignancies in interventional cardiologists or electrophysiologists have raised concern. 8 Furthermore, the finding of primarily left-sided tumors is of interest because tumors should be equally distributed between right and left. The finding of the disproportionate left-sided head malignancies is important because the left-side of the operator head is as twice as exposed when compared with the right, as the cardiologist stands during the procedure on the right of the patient with the radiation source to the left. 8 The National Cancer Institute estimates an annual incidence of 0.2% of brain and other nervous system cancer in the general population. However, the true incidence or lifetime risk of healthcare worker working with radiation is currently unknown.
With regard to a protective cap, a prior observational study assessed a lead cap that is 1.14 kg in weight and provides 0.5mm lead equivalent protection 12 showed a significant reduction in operator radiation exposure with the cap. The cap tested in our study is <1/20 the weight (53 versus 1140 g) and so is likely to be much better tolerated by healthcare workers as demonstrated in our survey.
Lange et al 11 randomized 210 patients undergoing coronary angiography alone to a 1-piece lead drape with a central cut out for femoral access. The trial demonstrated significant reductions in operator dose for both radial and femoral access consistent in magnitude with the results of our study. However, our design builds further on this study with a 2-piece drape that is reusable and can be easily covered in sterile bags and the top drape can be rapidly removed if imaging of iliac or femoral arteries are needed. Given that the lead shields are reusable, the costs are minimal per case.
Reducing dose is still important and so measures to reduce overall dose, including coning in (collimation), reducing extreme angles, reducing frame rate, and using fluoroscopy save, should be used whenever possible. 13 Orthopedic injuries remain an important cause of disability in healthcare workers 14 The advantage of a patient drape is that there is no additional weight burden to operator. Furthermore, the cap weighs 50 g so is lightweight. The lead drape also has the potential of minimizing other healthcare workers' radiation exposure, in addition to the primary operator.
The subgroup analyses from Radiation Protect showed clinically significant reductions in all of the prespecified subgroups, including diagnostic coronary angiography. This data suggest that the lead drape should be used in all cases and not in just high-dose cases (eg, CTO-PCI). Furthermore, given that 2 independent randomized trials have shown substantial dose reductions with a lead drape over the patient, this simple intervention should be adopted as standard of care in accordance with the ALARA principle.
Limitations
The primary limitation of this study is that we did not directly measure the patients' radiation exposure. Modeling studies suggest that a drape across a patient does not adversely affect patient dose. 15 However, another study has shown reductions in operator dose but increase in patient exposure. 16 Based on this, it is possible that the dose for the patient is increased with lead drapes. It is therefore important to also attempt to minimize patient dose using improved software upgrades designed to provide minimum possible dose and to use 7.5 frames/s instead of 15 frames/s when possible. 13 The net result of these multiple interventions is likely same or lower dose for patient and markedly reduced dose for healthcare workers. Further studies to assess the potential increase in patient doses should be performed. The second limitation is that there was a higher rate of patients with prior coronary artery bypass grafting in control group. However, the reduction in operator dose indexed for air kerma suggests that there is >70% reduction in operator dose when indexing for dose delivered to patient. The third limitation is that this was a single-center randomized trial. However, given the consistent findings with a previous independent randomized and the simplicity of the intervention, we think that the results have external validity.
Conclusions
The use of a specialized lead shield atop the patient and the cap significantly reduced operator radiation dose each independently. These protective measures can be incorporated into clinical practice and increase operators' safety. 
